Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q1 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
DLB:US | Dolby Laboratories, Inc. | Common share | - | US25659T1079 | $71.57 |
Company name | Dolby Laboratories |
---|---|
Sector | Information Technology / Technology Hardware & Equipment / Electronic Equipment, Instruments & Components / Electronic Equipment & Instruments |
Business address | 1275 MARKET STREET SAN FRANCISCO CA 94103 415 558 0200 |
Mailing address | 1275 MARKET STREET SAN FRANCISCO CA 94103 |
Website | www.dolby.com |